Nova (NVMI) Financials

$184.16 +4.38 (+2.44%)

As of 04:00 PM Eastern

Annual Income Statements for Nova

This table shows Nova's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	19	16	9.64	46	54	35	48	93	140	136	184
Consolidated Net Income / (Loss)	19	16	9.64	46	54	35	48	93	140	136	184
Net Income / (Loss) Continuing Operations	19	16	9.64	46	54	35	48	93	140	136	184
Total Pre-Tax Income	17	12	11	60	63	39	56	109	158	155	216
Total Operating Income	17	12	10	58	60	36	56	112	150	132	188
Total Gross Profit	64	77	75	131	145	122	151	235	317	293	387
Total Revenue	121	149	164	222	251	225	269	416	571	518	672
Total Cost of Revenue	57	71	89	91	106	103	118	181	254	225	285
Total Operating Expenses	47	65	65	73	85	85	96	123	167	161	200
Selling, General & Admin Expense	4.46	8.51	6.84	8.10	8.74	10	13	17	24	20	24
Marketing Expense	13	16	22	25	28	28	30	40	53	52	65
Research & Development Expense	29	40	35	39	45	45	53	66	90	88	110
Total Other Income / (Expense), net	0.56	0.64	1.22	2.28	2.98	3.08	0.93	-3.13	8.48	22	29
Other Income / (Expense), net	-	-	-	-	2.98	3.08	0.93	-3.13	8.48	22	29
Income Tax Expense	-1.18	-3.50	1.74	14	9.05	4.32	8.59	16	18	18	33
Basic Earnings per Share	$0.68	$0.58	$0.35	$1.68	$1.94	$1.26	$1.71	$3.28	$4.89	$4.73	$6.31
Weighted Average Basic Shares Outstanding	27.45M	27.19M	27.17M	27.70M	28.02M	27.90M	28.10M	28.37M	28.70M	28.83M	29.11M
Diluted Earnings per Share	$0.67	$0.57	$0.35	$1.63	$1.89	$1.23	$1.65	$3.12	$4.43	$4.28	$5.75
Weighted Average Diluted Shares Outstanding	27.81M	27.51M	27.50M	28.52M	28.77M	28.57M	28.95M	29.82M	31.87M	32.09M	32.14M
Weighted Average Basic & Diluted Shares Outstanding	27.14M	27.09M	27.35M	27.90M	27.92M	28.01M	28.18M	28.58M	28.68M	29.01M	29.28M

No quarterly income statements for Nova are available.

This table details how cash moves in and out of Nova's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-3.89	14	-7.33	7.29	-4.82	8.87	201	-106	-15	-4.15	50
Net Cash From Operating Activities	34	26	-4.16	62	37	41	60	132	120	124	235
Net Cash From Continuing Operating Activities	34	26	-4.16	62	37	41	60	132	120	124	235
Net Income / (Loss) Continuing Operations	19	16	9.64	46	54	35	48	93	140	136	184
Consolidated Net Income / (Loss)	19	16	9.64	46	54	35	48	93	140	136	184
Depreciation Expense	3.95	4.60	4.05	3.62	5.07	5.40	5.88	6.48	8.62	10	12
Amortization Expense	0.00	5.02	2.55	2.56	2.61	2.63	3.37	8.40	8.98	4.14	-0.26
Non-Cash Adjustments To Reconcile Net Income	2.30	2.66	2.96	2.78	5.34	4.58	6.72	11	25	23	32
Changes in Operating Assets and Liabilities, net	8.64	-2.22	-23	6.39	-30	-7.09	-3.62	13	-63	-50	8.12
Net Cash From Investing Activities	-33	-9.72	-4.38	-57	-37	-25	-42	-239	-100	-125	-136
Net Cash From Continuing Investing Activities	-33	-9.72	-4.38	-57	-37	-25	-42	-239	-100	-125	-136
Purchase of Property, Plant & Equipment	-5.23	-4.37	-3.13	-6.30	-3.68	-21	-6.44	-4.82	-21	-17	-17
Acquisitions	0.00	-45	-	-	-	-	0.00	0.00	-78	0.00	0.00
Purchase of Investments	0.00	0.00	-1.25	-51	-33	0.00	0.00	-215	-212	-274	-272
Sale and/or Maturity of Investments	-30	40	0.00	0.00	0.00	0.00	0.00	13	81	195	246
Other Investing Activities, net	1.62	0.00	0.00	0.00	0.00	-4.18	-36	-31	130	-30	-94
Net Cash From Financing Activities	-4.14	-1.98	1.21	2.62	-4.44	-6.67	181	0.01	-30	0.01	-48
Net Cash From Continuing Financing Activities	-4.14	-1.98	1.21	2.62	-4.44	-6.67	181	0.01	-30	0.01	-48
Repurchase of Common Equity	-6.73	-4.30	-0.94	0.00	-4.80	-7.16	-13	0.00	-21	-0.11	-30
Issuance of Debt	-	-	-	-	0.00	0.00	194	0.00	0.00	0.00	-19
Other Financing Activities, net	2.59	2.32	2.15	2.62	0.36	0.49	0.37	0.01	-8.39	0.12	0.16
Effect of Exchange Rate Changes	-	-	-	-	-0.83	0.30	1.36	0.62	-4.45	-2.36	-0.32
Cash Income Taxes Paid	0.14	0.08	1.90	8.16	13	8.34	3.98	13	23	27	30

No quarterly cash flow statements for Nova are available.

This table presents Nova's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	173	207	219	283	333	400	656	805	984	1,134	1,390
Total Current Assets	158	150	168	232	282	303	559	567	613	710	902
Cash & Equivalents	14	28	20	28	23	32	232	127	111	108	158
Short-Term Investments	109	69	71	121	153	155	192	283	262	336	429
Accounts Receivable	16	19	43	41	54	52	63	68	109	111	139
Inventories, net	16	28	29	35	42	48	62	79	117	138	157
Other Current Assets	2.93	2.68	4.84	6.95	10	17	9.78	9.24	14	17	19
Plant, Property, & Equipment, net	11	11	10	14	14	31	34	34	56	67	82
Total Noncurrent Assets	2.57	46	41	37	38	67	59	199	314	356	406
Long-Term Investments	-	-	-	-	0.00	2.81	0.00	137	156	198	234
Goodwill	0.00	20	20	20	20	20	20	20	49	50	48
Intangible Assets	0.00	18	15	13	10	7.56	5.06	2.60	44	39	31
Noncurrent Deferred & Refundable Income Taxes	1.65	5.74	3.02	1.96	3.87	4.55	2.87	6.16	20	24	32
Other Noncurrent Operating Assets	0.17	0.21	0.23	0.36	0.53	29	30	31	46	45	61
Other Noncurrent Nonoperating Assets	0.75	2.26	2.18	2.25	3.39	3.21	1.48	1.60	0.00	0.00	0.00
Total Liabilities & Shareholders' Equity	173	207	219	283	333	400	656	805	984	1,134	1,390
Total Liabilities	30	46	44	57	53	86	284	331	397	383	463
Total Current Liabilities	27	37	39	52	48	46	61	288	134	323	388
Short-Term Debt	-	-	-	-	-	-	0.00	183	0.00	198	181
Accounts Payable	12	14	17	16	19	21	24	36	43	35	60
Current Deferred Revenue	3.02	5.83	4.07	10	3.98	2.26	4.72	15	31	42	73
Other Current Liabilities	13	16	18	26	25	23	32	53	61	48	75
Total Noncurrent Liabilities	2.50	9.05	4.84	4.42	4.61	40	223	43	263	60	74
Noncurrent Deferred & Payable Income Tax Liabilities	0.00	5.76	1.09	0.00	-	-	-	0.00	12	11	8.50
Noncurrent Employee Benefit Liabilities	2.47	2.47	2.42	2.59	2.25	3.29	3.72	3.69	3.60	3.36	3.30
Other Noncurrent Operating Liabilities	0.00	0.82	1.33	1.83	2.36	36	41	40	51	46	63
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	144	161	175	227	281	315	372	474	587	751	928
Total Preferred & Common Equity	144	161	175	227	281	315	372	474	587	751	928
Total Common Equity	144	161	175	227	281	315	372	474	587	751	928
Common Stock	119	124	129	123	122	121	129	140	121	140	135
Retained Earnings	32	48	58	104	159	194	242	335	478	614	798
Accumulated Other Comprehensive Income / (Loss)	-1.18	-0.11	-0.05	0.11	-0.19	0.02	0.57	-0.81	-13	-3.33	-5.30

No quarterly balance sheets for Nova are available.

This table displays calculated financial ratios and metrics derived from Nova's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	8.17%	23.13%	10.36%	35.44%	13.13%	-10.44%	19.78%	54.46%	37.16%	-9.25%	29.83%
EBITDA Growth	31.58%	1.63%	-20.95%	281.85%	11.11%	-33.19%	38.37%	88.80%	41.80%	-3.88%	34.63%
EBIT Growth	37.12%	-31.52%	-12.22%	468.75%	9.70%	-37.74%	43.08%	93.38%	44.99%	-2.34%	39.81%
NOPAT Growth	81.32%	-17.47%	-42.18%	418.94%	15.92%	-37.42%	45.31%	103.24%	38.57%	-12.18%	36.72%
Net Income Growth	77.38%	-15.69%	-38.67%	381.74%	17.04%	-35.32%	36.21%	94.34%	50.60%	-2.78%	34.81%
EPS Growth	76.32%	-14.93%	-38.60%	365.71%	15.95%	-34.92%	34.15%	89.09%	41.99%	-3.39%	34.35%
Operating Cash Flow Growth	205.19%	-23.12%	-116.13%	1,585.84%	-39.94%	9.61%	48.07%	119.51%	-9.62%	3.34%	90.45%
Free Cash Flow Firm Growth	521.13%	-206.30%	60.73%	553.95%	-49.51%	-54.42%	311.41%	137.26%	-115.57%	457.73%	179.99%
Invested Capital Growth	-32.46%	237.16%	32.10%	-7.59%	34.65%	20.41%	-0.87%	-15.31%	146.67%	20.89%	-6.18%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	52.74%	51.90%	45.93%	59.10%	57.83%	54.16%	56.11%	56.58%	55.54%	56.61%	57.57%
EBITDA Margin	17.30%	14.28%	10.23%	28.83%	28.32%	21.13%	24.40%	29.83%	30.84%	32.67%	33.87%
Operating Margin	14.02%	7.80%	6.20%	26.05%	24.07%	16.19%	20.63%	27.01%	26.27%	25.54%	27.89%
EBIT Margin	14.02%	7.80%	6.20%	26.05%	25.26%	17.56%	20.97%	26.26%	27.76%	29.87%	32.17%
Profit (Net Income) Margin	15.46%	10.59%	5.88%	20.93%	21.65%	15.64%	17.78%	22.37%	24.57%	26.32%	27.33%
Tax Burden Percent	106.74%	128.64%	84.73%	77.31%	85.73%	89.07%	84.80%	85.22%	88.51%	88.11%	84.96%
Interest Burden Percent	103.33%	105.55%	111.96%	103.94%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	-6.74%	-28.64%	15.27%	22.69%	14.27%	10.93%	15.20%	14.78%	11.49%	11.89%	15.04%
Return on Invested Capital (ROIC)	79.45%	37.21%	12.02%	56.95%	58.58%	28.99%	38.72%	85.59%	74.61%	41.69%	53.73%
ROIC Less NNEP Spread (ROIC-NNEP)	78.92%	36.47%	10.95%	55.51%	57.03%	27.51%	38.36%	86.45%	72.48%	36.61%	49.23%
Return on Net Nonoperating Assets (RNNOA)	-65.74%	-26.88%	-6.27%	-33.80%	-37.15%	-17.17%	-24.75%	-63.56%	-48.17%	-21.31%	-31.84%
Return on Equity (ROE)	13.70%	10.32%	5.74%	23.15%	21.43%	11.82%	13.97%	22.03%	26.44%	20.38%	21.90%
Cash Return on Invested Capital (CROIC)	118.19%	-71.30%	-15.64%	64.84%	29.05%	10.47%	39.59%	102.18%	-10.01%	22.77%	60.11%
Operating Return on Assets (OROA)	10.08%	6.09%	4.77%	23.04%	20.57%	10.76%	10.70%	14.96%	17.71%	14.61%	17.14%
Return on Assets (ROA)	11.12%	8.26%	4.53%	18.51%	17.63%	9.59%	9.07%	12.75%	15.67%	12.87%	14.56%
Return on Common Equity (ROCE)	13.70%	10.32%	5.74%	23.15%	21.43%	11.82%	13.97%	22.03%	26.44%	20.38%	21.90%
Return on Equity Simple (ROE_SIMPLE)	12.99%	9.76%	5.52%	20.49%	19.37%	11.18%	12.89%	19.65%	23.89%	18.16%	19.81%
Net Operating Profit after Tax (NOPAT)	18	15	8.61	45	52	32	47	96	133	117	159
NOPAT Margin	14.97%	10.03%	5.26%	20.14%	20.63%	14.42%	17.49%	23.02%	23.25%	22.50%	23.70%
Net Nonoperating Expense Percent (NNEP)	0.53%	0.74%	1.07%	1.44%	1.55%	1.48%	0.35%	-0.86%	2.13%	5.08%	4.50%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	16.94%	12.29%	14.38%
Cost of Revenue to Revenue	47.26%	48.10%	54.07%	40.90%	42.17%	45.84%	43.89%	43.42%	44.46%	43.39%	42.43%
SG&A Expenses to Revenue	3.70%	5.73%	4.17%	3.65%	3.48%	4.48%	4.65%	4.16%	4.18%	3.94%	3.60%
R&D to Revenue	24.46%	26.73%	21.35%	17.55%	18.10%	19.79%	19.68%	15.83%	15.85%	17.00%	16.40%
Operating Expenses to Revenue	38.72%	44.10%	39.73%	33.05%	33.76%	37.98%	35.48%	29.57%	29.27%	31.07%	29.68%
Earnings before Interest and Taxes (EBIT)	17	12	10	58	63	39	56	109	158	155	216
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	21	21	17	64	71	48	66	124	176	169	228
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.97	1.65	2.04	3.13	2.26	3.36	5.32	8.71	3.98	5.25	6.16
Price to Tangible Book Value (P/TBV)	1.97	2.16	2.56	3.66	2.54	3.68	5.71	9.15	4.72	5.96	6.74
Price to Revenue (P/Rev)	2.35	1.79	2.18	3.19	2.53	4.70	7.34	9.92	4.09	7.61	8.50
Price to Earnings (P/E)	15.20	16.91	36.97	15.25	11.69	30.03	41.27	44.34	16.65	28.91	31.10
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	6.58%	5.91%	2.70%	6.56%	8.56%	3.33%	2.42%	2.26%	6.01%	3.46%	3.22%
Enterprise Value to Invested Capital (EV/IC)	8.76	2.73	3.26	7.42	4.53	7.09	14.30	36.68	7.91	11.43	17.68
Enterprise Value to Revenue (EV/Rev)	1.33	1.14	1.62	2.52	1.83	3.86	6.43	9.04	3.51	6.75	7.55
Enterprise Value to EBITDA (EV/EBITDA)	7.69	7.97	15.85	8.74	6.46	18.25	26.35	30.32	11.37	20.67	22.28
Enterprise Value to EBIT (EV/EBIT)	9.49	14.59	26.13	9.68	7.25	21.96	30.66	34.45	12.64	22.60	23.46
Enterprise Value to NOPAT (EV/NOPAT)	8.89	11.34	30.84	12.52	8.87	26.74	36.76	39.30	15.08	30.00	31.85
Enterprise Value to Operating Cash Flow (EV/OCF)	4.79	6.55	0.00	9.05	12.38	21.31	28.75	28.45	16.75	28.30	21.57
Enterprise Value to Free Cash Flow (EV/FCFF)	5.98	0.00	0.00	11.00	17.89	74.03	35.95	32.92	0.00	54.92	28.47
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.48	0.39	0.33	0.26	0.19
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.48	0.00	0.33	0.00	0.00
Financial Leverage	-0.83	-0.74	-0.57	-0.61	-0.65	-0.62	-0.65	-0.74	-0.66	-0.58	-0.65
Leverage Ratio	1.23	1.25	1.27	1.25	1.22	1.23	1.54	1.73	1.69	1.58	1.50
Compound Leverage Factor	1.27	1.32	1.42	1.30	1.22	1.23	1.54	1.73	1.69	1.58	1.50
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	32.49%	27.87%	25.07%	20.84%	16.29%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	27.87%	0.00%	20.84%	16.29%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	32.49%	0.00%	25.07%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	67.51%	72.13%	74.93%	79.16%	83.71%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	2.72	1.47	1.12	1.17	0.79
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	-3.73	-2.94	-1.89	-2.62	-2.81
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	2.72	0.00	1.12	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	3.79	1.91	1.48	1.70	1.13
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	-5.20	-3.81	-2.51	-3.81	-4.01
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	3.79	0.00	1.48	0.00	0.00
Altman Z-Score	7.91	5.33	6.85	10.25	10.12	9.71	6.30	9.44	5.90	8.25	9.66
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	5.80	4.04	4.30	4.45	5.86	6.55	9.17	1.97	4.57	2.20	2.32
Quick Ratio	5.09	3.12	3.42	3.65	4.77	5.15	8.00	1.66	3.60	1.72	1.87
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	27	-29	-11	51	26	12	48	114	-18	64	178
Operating Cash Flow to CapEx	640.87%	589.73%	-132.78%	981.91%	1,009.35%	191.32%	935.17%	2,746.30%	560.85%	718.70%	1,366.63%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.72	0.78	0.77	0.88	0.81	0.61	0.51	0.57	0.64	0.49	0.53
Accounts Receivable Turnover	5.54	8.58	5.32	5.31	5.32	4.28	4.69	6.32	6.42	4.70	5.37
Inventory Turnover	3.33	3.26	3.11	2.83	2.76	2.29	2.15	2.57	2.60	1.76	1.94
Fixed Asset Turnover	11.05	13.19	15.55	18.57	18.17	10.15	8.32	12.13	12.63	8.44	9.05
Accounts Payable Turnover	4.20	5.51	5.74	5.63	6.09	5.19	5.28	5.99	6.43	5.77	6.02
Days Sales Outstanding (DSO)	65.84	42.53	68.67	68.71	68.66	85.31	77.85	57.79	56.84	77.72	68.01
Days Inventory Outstanding (DIO)	109.57	111.87	117.26	128.99	132.19	159.59	169.94	141.82	140.43	206.90	188.57
Days Payable Outstanding (DPO)	86.97	66.29	63.59	64.83	59.92	70.32	69.16	60.92	56.78	63.25	60.60
Cash Conversion Cycle (CCC)	88.43	88.12	122.34	132.87	140.93	174.58	178.64	138.68	140.50	221.38	195.98
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	18	62	82	75	102	122	121	103	253	306	287
Invested Capital Turnover	5.31	3.71	2.29	2.83	2.84	2.01	2.21	3.72	3.21	1.85	2.27
Increase / (Decrease) in Invested Capital	-8.80	43	20	-6.19	26	21	-1.06	-19	151	53	-19
Enterprise Value (EV)	161	169	266	560	460	867	1,732	3,763	2,002	3,497	5,075
Market Capitalization	283	266	357	709	636	1,056	1,977	4,128	2,334	3,940	5,714
Book Value per Share	$5.26	$5.94	$6.45	$8.29	$10.06	$11.27	$13.27	$16.81	$20.54	$26.18	$31.98
Tangible Book Value per Share	$5.26	$4.53	$5.14	$7.09	$8.98	$10.28	$12.37	$16.01	$17.30	$23.07	$29.23
Total Capital	144	161	175	227	281	315	550	657	783	948	1,108
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	179	183	196	198	181
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	179	0.00	196	0.00	0.00
Net Debt	-123	-97	-91	-149	-176	-189	-245	-365	-333	-444	-640
Capital Expenditures (CapEx)	5.23	4.37	3.13	6.30	3.68	21	6.44	4.82	21	17	17
Debt-free, Cash-free Net Working Capital (DFCFNWC)	7.55	16	38	31	58	70	74	51	105	141	108
Debt-free Net Working Capital (DFNWC)	130	113	129	180	233	257	498	462	479	585	694
Net Working Capital (NWC)	130	113	129	180	233	257	498	279	479	387	514
Net Nonoperating Expense (NNE)	-0.60	-0.83	-1.03	-1.76	-2.56	-2.74	-0.79	2.67	-7.50	-20	-24
Net Nonoperating Obligations (NNO)	-125	-99	-93	-151	-179	-192	-250	-371	-334	-445	-641
Total Depreciation and Amortization (D&A)	3.95	9.62	6.59	6.18	7.68	8.03	9.25	15	18	14	11
Debt-free, Cash-free Net Working Capital to Revenue	6.26%	10.63%	23.00%	13.83%	22.96%	31.31%	27.43%	12.37%	18.46%	27.30%	16.02%
Debt-free Net Working Capital to Revenue	108.18%	75.97%	78.49%	80.99%	92.98%	114.13%	184.77%	110.94%	83.91%	112.97%	103.26%
Net Working Capital to Revenue	108.18%	75.97%	78.49%	80.99%	92.98%	114.13%	184.77%	66.95%	83.91%	74.80%	76.40%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.68	$0.58	$0.35	$1.68	$1.94	$1.26	$1.71	$3.28	$4.89	$4.73	$6.31
Adjusted Weighted Average Basic Shares Outstanding	27.45M	27.19M	27.18M	27.70M	28.02M	27.90M	28.10M	28.37M	28.70M	28.83M	29.11M
Adjusted Diluted Earnings per Share	$0.67	$0.57	$0.35	$1.63	$1.89	$1.23	$1.65	$3.12	$4.40	$4.28	$5.75
Adjusted Weighted Average Diluted Shares Outstanding	27.81M	27.51M	27.50M	28.52M	28.77M	28.57M	28.95M	29.82M	31.87M	32.09M	32.14M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	27.14M	27.09M	27.35M	27.90M	27.92M	28.01M	28.18M	28.58M	28.68M	29.01M	29.28M
Normalized Net Operating Profit after Tax (NOPAT)	12	8.11	8.61	45	52	32	47	96	133	117	159
Normalized NOPAT Margin	9.81%	5.46%	5.26%	20.14%	20.63%	14.42%	17.49%	23.02%	23.25%	22.50%	23.70%
Pre Tax Income Margin	14.49%	8.23%	6.94%	27.07%	25.26%	17.56%	20.97%	26.26%	27.76%	29.87%	32.17%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	36.06%	27.36%	9.72%	0.00%	8.83%	20.35%	26.19%	0.00%	15.27%	0.08%	16.33%

No quarterly metrics and ratios for Nova are available.

Frequently Asked Questions About Nova's Financials

When does Nova's financial year end?

According to the most recent income statement we have on file, Nova's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Nova's net income changed over the last 10 years?

Nova's net income appears to be on an upward trend, with a most recent value of $183.76 million in 2024, rising from $18.65 million in 2014. The previous period was $136.31 million in 2023.

What is Nova's operating income?

Nova's total operating income in 2024 was $187.54 million, based on the following breakdown:

Total Gross Profit: $387.09 million
Total Operating Expenses: $199.55 million

How has Nova revenue changed over the last 10 years?

Over the last 10 years, Nova's total revenue changed from $120.62 million in 2014 to $672.40 million in 2024, a change of 457.5%.

How much debt does Nova have?

Nova's total liabilities were at $462.63 million at the end of 2024, a 20.8% increase from 2023, and a 1,457.8% increase since 2014.

How much cash does Nova have?

In the past 10 years, Nova's cash and equivalents has ranged from $13.65 million in 2014 to $232.30 million in 2020, and is currently $157.78 million as of their latest financial filing in 2024.

How has Nova's book value per share changed over the last 10 years?

Over the last 10 years, Nova's book value per share changed from 5.26 in 2014 to 31.98 in 2024, a change of 507.6%.

Remove Ads

Related Companies

This page (NASDAQ:NVMI) was last updated on 4/14/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nova (NVMI) Financials

Frequently Asked Questions About Nova's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nova (NVMI) Financials

Annual Income Statements for Nova

Quarterly Income Statements for Nova

Annual Cash Flow Statements for Nova

Quarterly Cash Flow Statements for Nova

Annual Balance Sheets for Nova

Quarterly Balance Sheets for Nova

Annual Metrics and Ratios for Nova

Quarterly Metrics and Ratios for Nova

Frequently Asked Questions About Nova's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools